Detection of IDH mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry
Authors:
Open Access
- 6 November 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-8
Abstract
Desorption electrospray ionization (DESI) tandem mass spectrometry (MS) is used to assess mutation status of isocitrate dehydrogenase (IDH) in human gliomas. Due to the diffuse nature of gliomas, total gross resection is not normally achieved during surgery, leading to tumor recurrence. The mutation status of IDH has clinical significance due to better prognosis in IDH-mutant patients. The mutant IDH converts alpha-ketoglutaric acid (α-KG) into 2-hydroxyglutarate (2HG), which accumulates abnormally in cells. Immunohistochemical staining (IHC) and genetic testing, the gold standards, are incompatible with intraoperative applications but DESI tandem mass spectrometry (MS/MS) can be used to assess the mutation status of IDH enzyme from tissue intraoperatively. Here, on off-line evaluation is made of the performance of two different types of mass spectrometers in characterization of IDH mutation status. The intensity of 2HG is measured against glutamate (Glu), an intrinsic reference molecule, in both tandem MS measurements. In both cases using DESI clear separation between IDH-mutant (mut) and IDH-wildtype (wt) samples (p < 0.0001) is observed, despite the short analysis time. Due to the higher detection sensitivity, multiple reaction monitoring experiments using a triple quadrupole show slightly better performance compared to product ion MS/MS performed on a simple linear ion trap. Both DESI-MS platforms are capable of providing information on IDH mutation status, which might in future be used at the time of surgery to support decision-making on resection regions, especially at tumor margins.Keywords
Funding Information
- IMAT NIH (R33CA240181, R33CA240181, R33CA240181, R33CA240181)
- Purdue University Center for Cancer Research (P30 CA 023168, P30 CA 023168)
- Waters Corporation (40002775, 40002775)
This publication has 40 references indexed in Scilit:
- Rapid determination of isocitrate dehydrogenase mutation status of human gliomas by extraction nanoelectrospray using a miniature mass spectrometerAnalytical and Bioanalytical Chemistry, 2019
- Diagnostic Accuracy of Cytology Smear and Frozen Section in GliomaAsian Pacific Journal of Cancer Prevention, 2019
- Logical MS/MS scans: a new set of operations for tandem mass spectrometryThe Analyst, 2018
- Intraoperative Raman SpectroscopyNeurosurgery Clinics of North America, 2017
- Magnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in GliomasMetabolites, 2017
- Utility of neurological smears for intrasurgical brain cancer diagnostics and tumour cell percentage by DESI-MSThe Analyst, 2017
- Brain shift in neuronavigation of brain tumors: A reviewMedical Image Analysis, 2017
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade GliomasNew England Journal of Medicine, 2015
- Suitability of infrared spectroscopic imaging as an intraoperative tool in cerebral glioma surgeryAnalytical and Bioanalytical Chemistry, 2008
- Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional ExperienceAnnals of Surgical Oncology, 2008